How to Plan a Peptide Cycle From Start to Finish

The Planning Framework

Here's how we think about planning a peptide cycle, stripped down to the essentials. Before you order anything, answer four questions:

1. What's the research question? "I want to see if BPC-157 accelerates tendon recovery" is specific and testable. "I want to try peptides" is not. The more focused your goal, the better you can structure the protocol and evaluate results.

2. What does the literature support? Look at published research for the peptide you're considering. What doses were used? What timelines showed effects? What endpoints were measured? Don't just read forum posts — go to the actual study data. Our peptide guides summarize this for each compound.

3. How will you measure results? Subjective "I feel better" is worth something, but objective measurements are worth more. Photos, measurements, performance metrics, sleep data, bloodwork — decide what you'll track before you start.

4. What's the exit plan? Every cycle should have a defined endpoint. Some peptides (like BPC-157 for injury recovery) have a natural stopping point when the issue resolves. Others (like semaglutide for weight management) may involve ongoing use. Know which category yours falls into.

How Long Should You Run?

This varies dramatically by peptide. Here are general ranges based on published research and common protocols:

The biggest mistake we see? Stopping too early. Someone runs CJC-1295 + Ipamorelin for three weeks, sees minimal changes, and concludes it doesn't work. Growth hormone effects on body composition take 6-12 weeks to become measurable. Three weeks isn't a fair test.

Supply Calculation

Nothing's worse than running out of peptide mid-cycle. Here's the formula:

Vials needed = (Daily dose × Days in cycle) ÷ Peptide per vial

Example: BPC-157, 250 mcg twice daily for 30 days.

250 mcg × 2 × 30 = 15,000 mcg = 15 mg total

15 mg ÷ 5 mg per vial = 3 vials

Add one extra vial for waste (dead space in syringes, occasional spills, reconstitution mistakes). So order 4 vials. Better to have one leftover than to break your protocol because you're counting the last few units in a vial.

For peptides with dose escalation (like semaglutide), calculate each phase separately and add them up. Don't forget that the maintenance dose at the end of escalation is usually the highest consumption phase.

Dose Escalation

Some peptides should be started at a lower dose and gradually increased. This is most critical for GLP-1 agonists, where jumping to the full dose causes significant nausea in most people.

Semaglutide's standard escalation schedule from the clinical trials:

• Weeks 1-4: 0.25 mg/week
• Weeks 5-8: 0.5 mg/week
• Weeks 9-12: 1.0 mg/week
• Weeks 13-16: 1.7 mg/week
• Week 17+: 2.4 mg/week (maintenance)

This isn't optional. Skipping escalation to "get results faster" just gets you more nausea. The body needs time to adapt to delayed gastric emptying and changed appetite signaling.

Growth hormone secretagogues like CJC-1295 and ipamorelin typically don't require formal escalation, but some researchers start at half dose for the first week to assess tolerance before moving to full dose. Reasonable caution, not strictly necessary.

BPC-157 and TB-500 are typically run at the full research dose from day one. No escalation needed.

Keeping a Log

This is the part everyone skips and everyone regrets skipping.

You don't need anything elaborate. A simple spreadsheet or even a notes app on your phone works. What to track daily:

• Date and time of injection(s)
• Peptide, dose, and injection site
• Any side effects (nausea, injection site reaction, headache, etc.)
• Relevant metrics — whatever you decided to measure in the planning phase. Weight, sleep quality (1-10), pain level, energy level, photos on a set schedule.
• Anything unusual — missed a dose, changed diet significantly, started a new medication, got sick.

Why bother? Because memory is unreliable over weeks. At the end of a 12-week cycle, you won't remember whether the sleep improvement started in week 2 or week 5. Your log will know.

The log also helps if you run the same protocol again later. You'll have actual data to compare against, not vague recollections.

When to Stop

The protocol says 8 weeks but you're at week 6 and nothing's happening. Do you keep going?

Generally, yes. If you planned a cycle duration based on published research timelines, trust the timeline. Early impatience kills more cycles than genuine non-response. Give the full planned duration unless you're experiencing side effects that warrant stopping.

Reasons to stop early:

• Adverse reactions that don't resolve with dose reduction
• Signs of contamination — cloudy solution, injection site infections, persistent redness or swelling
• Goal achieved — your injury healed at week 4, no need to run BPC-157 through week 8

Reasons to keep going:

• "I don't feel anything yet" at the halfway point of a reasonable cycle — many peptide effects are gradual and sub-perceptual
• Mild, transient side effects that are resolving over time
• You're seeing partial results and the timeline hasn't been reached yet

After the cycle, take time to review your log and assess results before deciding on a repeat cycle, a different peptide, or a break.